Suffering and dying in cancer patients. Research frontiers in controlling confusion, cachexia, and dyspnea.

Program directors acknowledge that critically ill patients, having few or no therapeutic alternatives, can have a negative impact on House Staffand students. They urged an exposure to outpatient oncology, where treatment successes are more frequently found.'

[1]  E. G. Nabel,et al.  NATIONAL CANCER INSTITUTE , 1993, Definitions.

[2]  R. Twycross.  Palliative Medicine: Problem Areas in Pain and Symptom Management , 1995 .

[3]  N. Macdonald,et al.  Cachexia-anorexia-asthenia. , 1995, Journal of pain and symptom management.

[4]  J. S. Tenover.  Androgen administration to aging men. , 1994, Endocrinology and metabolism clinics of North America.

[5]  A. Donner,et al.  Evaluation of a palliative care service: problems and pitfalls , 1994, BMJ.

[6]  Victoria N. Ruff,et al.  Ethical issues in health care system reform. The provision of adequate health care. Council on Ethical and Judicial Affairs, American Medical Association. , 1994, JAMA.

[7]  L. de Raeve.  Ethical issues in palliative care research. , 1994, Palliative medicine.

[8]  K. Bonuck,et al.  The economic impact of high-technology home care. , 1994, The Hastings Center report.

[9]  J. O'fallon,et al.  Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Jett,et al.  Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Walsh,et al.  A Phase II Study of Delta-9-Tetrahydrocannabinol for Appetite Stimulation in Cancer-Associated Anorexia , 1994, Journal of palliative care.

[12]  A. Barbul,et al.  Arginine stimulates wound healing and immune function in elderly human beings. , 1993, Surgery.

[13]  N. Macdonald,et al.  Opioid hyperexcitability: the application of alternate opioid therapy , 1993, Pain.

[14]  K. Nelson,et al.  Metoclopramide in Anorexia Caused by Cancer-Associated Dyspepsia Syndrome (CADS) , 1993, Journal of palliative care.

[15]  D. Schaid,et al.  Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Ronald Melzack,et al.  Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence , 1993, Pain.

[17]  E. Bruera,et al.  Cognitive failure in cancer patients in clinical trials , 1993, The Lancet.

[18]  E. Bruera,et al.  Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. , 1992, Journal of pain and symptom management.

[19]  D. Langleben,et al.  Hemodynamic differences between continual positive and two types of negative pressure ventilation. , 1992, The American review of respiratory disease.

[20]  R. Mayer.  Training in medical oncology: regaining the luster. , 1991, Journal of the National Cancer Institute.

[21]  R. Portenoy,et al.  Chronic nausea and morphine-6-glucuronide. , 1991, Journal of pain and symptom management.

[22]  H. D. Mulligan,et al.  Lipolytic factors associated with murine and human cancer cachexia. , 1990, Journal of the National Cancer Institute.

[23]  E. Bruera,et al.  Effects of morphine on the dyspnea of terminal cancer patients. , 1990, Journal of pain and symptom management.

[24]  E. Bruera,et al.  A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer , 1990, Cancer.

[25]  A. Mier.  Respiratory muscle weakness. , 1990, Respiratory medicine.

[26]  D. Schaid,et al.  Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. , 1990, Journal of the National Cancer Institute.

[27]  D. Schaid,et al.  A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia , 1990, Cancer.

[28]  J. Aisner,et al.  Treatment of cancer anorexia with megestrol acetate: impact on quality of life. , 1990, Oncology.

[29]  P. Storey,et al.  Subcutaneous infusions for control of cancer symptoms. , 1990, Journal of pain and symptom management.

[30]  H. Kimura,et al.  Respiration effect of synthetic progestin in small doses in normal men. , 1989, Chest.

[31]  I. Higginson,et al.  Measuring Symptoms in Terminal Cancer: Are Pain and Dyspnoea Controlled? , 1989, Journal of the Royal Society of Medicine.

[32]  E. Bruera,et al.  Use of the subcutaneous route for the administration of narcotics in patients with cancer pain , 1988, Cancer.

[33]  M. Slevin,et al.  Morphine intoxication in renal failure; the role of morphine-6-glucuronide. , 1986, British medical journal.

[34]  E. Bruera,et al.  Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. , 1985, Cancer treatment reports.

[35]  P. Sharman,et al.  Effects of codeine on the respiratory responses to exercise in healthy subjects. , 1983, British journal of clinical pharmacology.

[36]  M. Aubier,et al.  Diaphragmatic contractility enhanced by aminophylline: role of extracellular calcium. , 1983, Journal of applied physiology: respiratory, environmental and exercise physiology.

[37]  F. Ottery.  Rethinking nutritional support of the cancer patient: the new field of nutritional oncology. , 1994, Seminars in oncology.

[38]  A. Vigano,et al.  Anorexia and cachexia in advanced cancer patients. , 1994, Cancer surveys.

[39]  D. Landman,et al.  Use of pentoxifylline therapy for patients with AIDS-related wasting: pilot study. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  D. Schaid,et al.  Body-composition changes in patients who gain weight while receiving megestrol acetate. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  N. Macdonald.  Priorities in education and research in palliative care , 1993 .

[42]  D. Roberts,et al.  Proportional assist ventilation. Results of an initial clinical trial. , 1992, The American review of respiratory disease.

[43]  M. Younes.  Proportional assist ventilation, a new approach to ventilatory support. Theory. , 1992, The American review of respiratory disease.

[44]  N. Macdonald.  Palliative care--the fourth phase of cancer prevention. , 1991, Cancer detection and prevention.

[45]  S. Brown,et al.  Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[46]  M. Klempner,et al.  The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. , 1989, The New England journal of medicine.

[47]  R. Portenoy.  Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. , 1989, Journal of pain and symptom management.

[48]  A. Keats.  The effect of drugs on respiration in man. , 1985, Annual review of pharmacology and toxicology.

[49]  I. Johnston.  Advances in Clinical Nutrition , 1983, Springer Netherlands.

[50]  C. Campbell,et al.  Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. , 1983, Annals of internal medicine.